Last reviewed · How we verify
NCT04610697: CRFMHC
Cognitive Remediation in Forensic Mental Health Care
NA trial testing Cognitive Remediation in Psychotic Disorders in 30 participants. Currently enrolling.
10 February 2026
Quick facts
| Lead sponsor | The Royal Ottawa Mental Health Centre |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 10 February 2020 |
| Primary completion | 10 February 2026 |
| Estimated completion | 10 February 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Cognitive Remediation — full drug profile →
- Active Control — full drug profile →
Conditions studied
- Psychotic Disorders — all drugs for Psychotic Disorders →
- ADHD — all drugs for ADHD →
- TBI (Traumatic Brain Injury) — all drugs for TBI (Traumatic Brain Injury) →
- Aggression — all drugs for Aggression →
Sponsor
The Royal Ottawa Mental Health Centre — full company profile →
Who can join
Adults 18 to 55, any sex, with Psychotic Disorders or ADHD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Forensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. One empirically-validated method to train executive functions is cognitive remediation, which consists of cognitive exercises combined with coaching. This trial investigates whether cognitive remediation can improve cognitive, functional, and clinical outcomes in forensic inpatients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04610697
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive Remediation
Trials testing the same drug.
- NCT07339124 — The Effect of Single Lung Ventilation Duration and Intraoperative Brain Oxygenation on Cognitive Function and Postoperat · not yet recruiting
- NCT07130669 — FACE Phase II (a Stage II Trial) · Phase 1, PHASE2 · not yet recruiting
- NCT06869616 — CRacking the HEterogeneity of Social Outcome Through Neuropsychophysiological Profiles · not yet recruiting
- NCT06932991 — Cognitive Stimulation Therapy - Effects on Cognitive and Functional Domains in Dementia - A Retrospective Data Review · completed
- NCT04103775 — Mechanisms of Cognitive Change · NA · terminated
Other recruiting trials for Psychotic Disorders
Currently open trials in the same condition.
- NCT07460453 — Racial Disparities in the Expression of Paranoia · NA · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
- NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting
Other The Royal Ottawa Mental Health Centre trials
Trials by the same sponsor.
- NCT07506070 — Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health H · NA · not yet recruiting
- NCT06773949 — Feasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression · NA · recruiting
- NCT06152705 — Comparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating Depression · NA · recruiting
- NCT07408934 — A Pilot Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme) · NA · enrolling by invitation
- NCT06528938 — Comparing the Efficacy of Accelerated vs. Standard fMRI-guided iTBS in Treating Adolescents Depression · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04610697 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Royal Ottawa Mental Health Centre
- Last refreshed: 12 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04610697.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing